MedTrace Logo

Testing Potential Synergistic Effects of Albuterol and Caffeine on Metabolic Rate

NCT02135965 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 8

Last updated 2015-12-18

No results posted yet for this study

Summary

The purpose of this study is to define a ratio of Caffeine and albuterol that gives a synergistic increase in metabolic rate.

Conditions

  • Healthy Volunteers

Interventions

DRUG

2mg of Albuterol

2mg of Albuterol on metabolic rate

DRUG

4mg of Albuterol

4mg of Albuterol on metabolic rate

DRUG

100mg of Caffeine

100mg of caffeine on metabolic rate

DRUG

200mg of Caffeine

200mg of Caffeine on metabolic rate

DRUG

Albuterol 2mg & Caffeine 100mg

Albuterol 2mg and 100mg of Caffeine

DRUG

Albuterol 2mg and Caffeine 200mg

Albuterol 2mg and Caffeine 200mg on metabolic rate

DRUG

Albuterol 4mg and Caffeine 100mg

Albuterol 4mg and Caffeine 100mg on metabolic rate

DRUG

Albuterol 4mg and Caffeine 200mg

Albuterol 4mg and Caffeine 200mg on metabolic rate

Sponsors & Collaborators

  • Pennington Biomedical Research Center

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-04-30
Primary Completion
2011-08-31
Completion
2011-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02135965 on ClinicalTrials.gov